Trials / Completed
CompletedNCT02192164
Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis
Non-interventional Study Of The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 126 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Pilot observational study to describe the relationship between the smoking status of a psoriatic individual and the success of etanercept therapy in psoriasis treatment
Detailed description
non-interventional study There is no sampling
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | smoking questionnaire | patients fill in a smoking questionnaire about their smoking habits |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2014-07-16
- Last updated
- 2017-06-28
- Results posted
- 2017-06-28
Locations
8 sites across 1 country: Hungary
Source: ClinicalTrials.gov record NCT02192164. Inclusion in this directory is not an endorsement.